| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CHIR-99021 | GDSC1000 | pan-cancer | AAC | -0.088 | 0.009 |
| mRNA | TPCA-1 | GDSC1000 | pan-cancer | AAC | -0.08 | 0.009 |
| mRNA | temsirolimus | FIMM | pan-cancer | AAC | 0.39 | 0.01 |
| mRNA | GSK1070916 | GDSC1000 | pan-cancer | AAC | -0.085 | 0.01 |
| mRNA | CP466722 | GDSC1000 | pan-cancer | AAC | -0.08 | 0.01 |
| mRNA | Genentech Cpd 10 | GDSC1000 | pan-cancer | AAC | -0.084 | 0.01 |
| mRNA | leptomycin B | CTRPv2 | pan-cancer | AAC | -0.092 | 0.01 |
| mRNA | Imatinib | CTRPv2 | pan-cancer | AAC | 0.098 | 0.01 |
| mRNA | navitoclax:MST-312 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.097 | 0.01 |
| mRNA | UNC0638 | CTRPv2 | pan-cancer | AAC | 0.096 | 0.01 |